Clinical Trials

Phase 3 Active not recruiting

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT02642809 2026-03-18

Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers

Phase 1 Completed

16 enrolled 13 charts

Gastrointestinal

Esophageal Neoplasms

NCT04214067 2026-03-18

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

164 enrolled

Carcinosarcoma

NCT07061977 2026-03-18

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Phase 3 Recruiting

336 enrolled

Locally Advanced Cervical Adenocarcinoma

NCT03315351 2026-03-13

TEP-Curie

Phase NA Completed

14 enrolled

Uterine Cervical Neoplasms

NCT07468903 2026-03-13

Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer

45 enrolled

Prostatic Neoplasms

NCT00525720 2026-03-09

Brachytherapy for Prostatic Carcinoma Patients

300 enrolled

Prostatic Neoplasms

NCT07182279 2026-03-09

Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer

Phase 1/2 Recruiting

29 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT00063882 2026-03-05

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer

Phase 3 Completed

588 enrolled 34 charts

Prostatic Neoplasms

NCT04473781 2026-03-02

Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer

Phase 1 Recruiting

17 enrolled

Carcinoma, Renal Cell

NCT01946529 2026-02-23

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

24 enrolled 11 charts

Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

NCT02899221 2026-02-20

Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation

Phase NA Completed

3 enrolled

1,060 enrolled 30 charts 1 FDA

Prostatic Neoplasms

NCT04221945 2026-02-20

KEYNOTE-A18

Phase 3 Completed

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT05320406 2026-02-12

REVELUTION

94 enrolled 13 charts

Phase 1/2 Active not recruiting

Prostatic Neoplasms

NCT03543189 2026-01-29

Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy

44 enrolled

Prostatic Diseases, Prostatic Neoplasms

NCT03955978 2026-01-06

TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer

10 enrolled

Endometrial Neoplasms

NCT01871766 2025-12-17

Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy

115 enrolled

Phase 2 Not yet recruiting

Rhabdomyosarcoma

NCT03422198 2025-12-12

SAVE

Phase 3 Recruiting

188 enrolled 15 charts

GynecologicSarcoma

Endometrial Clear Cell Adenocarcinoma

NCT07276360 2025-12-11

HypoRTCx-UG

278 enrolled

Uterine Cervical Neoplasms

NCT07232654 2025-12-01

Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC

30 enrolled

Uterine Cervical Neoplasms

NCT02595879 2025-11-13

Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer

21 enrolled 22 charts

Uterine Cervical Neoplasms

NCT03738228 2025-11-12

Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer

Phase 1 Completed

40 enrolled 17 charts

Uterine Cervical Neoplasms

NCT05754580 2025-11-05

High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer

53 enrolled

Prostatic Neoplasms

NCT05100472 2025-11-04

A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer

50 enrolled

Prostatic Neoplasms

NCT03634267 2025-10-14

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

26 enrolled

Phase EARLY_PHASE1 Completed

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT02467738 2025-09-19

Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer

30 enrolled

Head & Neck

Recurrent Head and Neck Carcinoma

NCT04253483 2025-09-17

Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

14 enrolled

Phase 1/2 Enrolling by invitation

Prostatic Neoplasms

NCT05893654 2025-09-15

MELCOM

10 enrolled

Dermatologic

Uveal Melanoma, Melanoma

NCT01655836 2025-09-11

High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer

42 enrolled

Phase 1 Not yet recruiting

Prostatic Neoplasms

NCT05570422 2025-09-11

A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01

70 enrolled

GastrointestinalGenitourinaryGynecologic

Uterine Cervical Neoplasms

NCT00924027 2025-09-05

A Study of Patients Receiving High-Dose Rate Brachytherapy

Phase 2 Completed

43 enrolled 13 charts

Biliary Tract Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT07152678 2025-09-03

BRIGHT-ESCC

60 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT07132073 2025-08-27

MRI-guided Locoregional SBRT Prostate Program

40 enrolled

Prostatic Neoplasms

NCT07132671 2025-08-20

MRI-guided Brachytherapy and Salvage SBRT Program

29 enrolled

Prostatic Neoplasms

NCT06023641 2025-08-19

Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease

135 enrolled

Rhabdomyosarcoma

NCT04945642 2025-07-15

HYDRA

52 enrolled

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT04634877 2025-06-09

KEYNOTE-B21

990 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT05715502 2025-04-30

FocaSaBra

100 enrolled

Prostatic Neoplasms, Recurrence

NCT05857631 2025-04-15

PARCERII

90 enrolled

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT03290534 2025-04-04

Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®

40 enrolled

Thoracic

Lung Neoplasms

NCT02346253 2025-04-03

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

146 enrolled

Prostatic Neoplasms

NCT04049747 2025-03-24

IP4-CHRONOS

Phase NA Completed

100 enrolled 23 charts

Prostatic Neoplasms

NCT00185744 2025-03-20

Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer

121 enrolled

Breast

Breast Neoplasms, Carcinoma, Ductal

NCT06882473 2025-03-18

A Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy with Adaptive Simultaneous Dose Escalation for Locally Advanced Cervical Cancer

20 enrolled

Phase 2 Not yet recruiting

Locally Advanced Cervical Cancer

NCT06872606 2025-03-12

SCRIPBOT

33 enrolled

Gastrointestinal

Rectal Neoplasms

NCT05224869 2025-02-26

Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer

Phase NA Terminated

10 enrolled

Neoplasms, Prostatic Neoplasms

NCT05663294 2025-02-03

PRISCILLA

150 enrolled

Breast

Breast Neoplasms

NCT03277469 2024-10-31

Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer

49 enrolled

Gynecologic Cancer

NCT06288373 2024-10-30

Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC

Phase 2/3 Recruiting

440 enrolled

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT06524778 2024-08-07

Single High-dose Brachytherapy for Giant Osteosarcoma Masses

16 enrolled